Mark Andrew Wilson, Chief Legal Officer at NEKTAR THERAPEUTICS (NKTR), sold 8,690 shares at $3.57 ($31K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Open-market sale of $31k NKTR by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |